BlackRock
IPSC icon

BlackRock’s Century Therapeutics IPSC Stock Holding History

BlackRock’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.8M Buy
8,091,768
+6,567,346
+431% +$15M ﹤0.01% 3262
2026
Q1 		$3.45M Buy
1,524,422
+922,556
+153% +$1.94M ﹤0.01% 3970
2025
Q4 		$599K Buy
601,866
+2,210
+0.4% +$1.35K ﹤0.01% 4442
2025
Q3 		$299K Sell
599,656
-325,027
-35% -$175K ﹤0.01% 4594
2025
Q2 		$517K Sell
924,683
-2,093,832
-69% -$1.12M ﹤0.01% 4433
2025
Q1 		$1.44M Sell
3,018,515
-18,733
-0.6% -$14.1K ﹤0.01% 4091
2024
Q4 		$3.07M Buy
3,037,248
+47,328
+2% +$64.4K ﹤0.01% 3908
2024
Q3 		$5.11M Buy
2,989,920
+94,307
+3% +$185K ﹤0.01% 3687
2024
Q2 		$7.38M Buy
2,895,613
+1,397,432
+93% +$4.42M ﹤0.01% 3537
2024
Q1 		$6.26M Sell
1,498,181
-20,815
-1% -$88.1K ﹤0.01% 3584
2023
Q4 		$5.04M Sell
1,518,996
-76,098
-5% -$139K ﹤0.01% 3690
2023
Q3 		$3.19M Sell
1,595,094
-20,080
-1% -$53.4K ﹤0.01% 3844
2023
Q2 		$5.1M Buy
1,615,174
+203,725
+14% +$657K ﹤0.01% 3724
2023
Q1 		$4.9M Sell
1,411,449
-42,296
-3% -$186K ﹤0.01% 3646
2022
Q4 		$7.46M Buy
1,453,745
+44,582
+3% +$421K ﹤0.01% 3531
2022
Q3 		$13.9M Buy
1,409,163
+102,978
+8% +$1.08M ﹤0.01% 3242
2022
Q2 		$11M Buy
1,306,185
+277,928
+27% +$2.73M ﹤0.01% 3460
2022
Q1 		$12.9M Buy
1,028,257
+200,834
+24% +$2.66M ﹤0.01% 3447
2021
Q4 		$13.1M Buy
827,423
+178,767
+28% +$3.36M ﹤0.01% 3511
2021
Q3 		$16.3M Buy
+648,656
New +$17.6M ﹤0.01% 3417

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

BlackRock's IPSC Position: Q2 2026 in Review

BlackRock increased its Century Therapeutics (IPSC) stake by 431% in Q2 2026, buying an estimated $15M and bringing the position to 8,091,768 shares worth $19.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3262.

BlackRock first reported a position in IPSC in Q3 2021 and has held it in 20 quarters since. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • BlackRock held 8,091,768 shares of Century Therapeutics worth $19.8M as of Q2 2026.
  • BlackRock bought 6,567,346 Century Therapeutics shares in Q2 2026, an estimated $15M.
  • Century Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3262 holding.
  • BlackRock first reported a position in Century Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.